1. Home
  2. PFO vs ELUT Comparison

PFO vs ELUT Comparison

Compare PFO & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFO
  • ELUT
  • Stock Information
  • Founded
  • PFO 1991
  • ELUT 2015
  • Country
  • PFO United States
  • ELUT United States
  • Employees
  • PFO N/A
  • ELUT N/A
  • Industry
  • PFO Finance Companies
  • ELUT Medical Specialities
  • Sector
  • PFO Finance
  • ELUT Health Care
  • Exchange
  • PFO Nasdaq
  • ELUT Nasdaq
  • Market Cap
  • PFO 123.7M
  • ELUT 111.2M
  • IPO Year
  • PFO N/A
  • ELUT 2020
  • Fundamental
  • Price
  • PFO $9.39
  • ELUT $3.65
  • Analyst Decision
  • PFO
  • ELUT Strong Buy
  • Analyst Count
  • PFO 0
  • ELUT 2
  • Target Price
  • PFO N/A
  • ELUT $10.00
  • AVG Volume (30 Days)
  • PFO 31.8K
  • ELUT 35.5K
  • Earning Date
  • PFO 01-01-0001
  • ELUT 11-11-2024
  • Dividend Yield
  • PFO 6.51%
  • ELUT N/A
  • EPS Growth
  • PFO N/A
  • ELUT N/A
  • EPS
  • PFO N/A
  • ELUT N/A
  • Revenue
  • PFO N/A
  • ELUT $24,987,000.00
  • Revenue This Year
  • PFO N/A
  • ELUT $9.65
  • Revenue Next Year
  • PFO N/A
  • ELUT $39.29
  • P/E Ratio
  • PFO N/A
  • ELUT N/A
  • Revenue Growth
  • PFO N/A
  • ELUT N/A
  • 52 Week Low
  • PFO $6.90
  • ELUT $1.14
  • 52 Week High
  • PFO $8.51
  • ELUT $5.24
  • Technical
  • Relative Strength Index (RSI)
  • PFO 58.47
  • ELUT 46.49
  • Support Level
  • PFO $9.33
  • ELUT $3.61
  • Resistance Level
  • PFO $9.49
  • ELUT $3.89
  • Average True Range (ATR)
  • PFO 0.07
  • ELUT 0.21
  • MACD
  • PFO -0.03
  • ELUT -0.02
  • Stochastic Oscillator
  • PFO 19.05
  • ELUT 33.90

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end investment company. Its primary investment objective is to produce high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: